Chinese Rocket Firm, Disease Research Lab to Test Space Pharmaceutical Payloads
4 Articles
4 Articles
Chinese rocket firm partners with research lab to test space pharmaceutical payloads
China's commercial rocket firm CAS Space unveiled a partnership with the Guangzhou Laboratory on Monday to jointly develop space pharmaceutical payloads, with plans to conduct suborbital flight verification using a reusable spacecraft in 2027.
CAS Space announced cooperation with Guangzhou Laboratory to conduct joint R&D for space pharmaceutical payloads. Suborbital flight verification with reusable vehicle is planned in 2027 and sending the first pharmaceutical payload to space with Lihong-2.
Chinese commercial space company CAS Space has announced that it will launch trials for pharmaceutical research in the first quarter of 2027. The first payloads will be delivered via a reusable spacecraft...
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
